Advances in therapeutics offer new and effective treatment options for inflammatory bowel disease, offering patients alternative options to systemic immunosuppression and pharmacological treatments.

Emerging treatments for inflammatory bowel disease

Anti-inflammatory therapy shows promise in chronic diseases like atherosclerosis, type 2 diabetes, and Alzheimer's disease, but faces limitations due to inflammatory response and survival needs.

Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities

Essential oils and their major compounds show promising anti-inflammatory activity in treating chronic inflammation through reduction of reactive oxygen and nitrogen species and NF-B inhibition.

Essential Oils and Their Major Compounds in the Treatment of Chronic Inflammation: A Review of Antioxidant Potential in Preclinical Studies and Molecular Mechanisms

Novel treatments targeting JAK, IL-12/IL-23, and leukocyte trafficking/migrating inhibitors show promise for improving treatment response rates and safety in inflammatory bowel diseases.

Novel and Emerging Therapies for Inflammatory Bowel Disease

New therapies focusing on blocking inflammation in the gastrointestinal tract can lead to more personalized treatments with higher success rates and fewer relapses in inflammatory bowel disease.

Emerging therapeutic options in inflammatory bowel disease

Nanoparticle-based drug delivery systems, inhaled corticosteroids, novel biologicals, gene therapy, and personalized medicine can improve treatment outcomes for chronic inflammatory respiratory diseases.

Advancing Treatment Strategies: A Comprehensive Review of Drug Delivery Innovations for Chronic Inflammatory Respiratory Diseases

Biologic drugs, particularly peptide inhibitors and monoclonal antibodies, show promise as promising treatments for chronic pulmonary diseases, with recent progress in randomized clinical trial outcomes.

Biologic drugs in the treatment of chronic inflammatory pulmonary diseases: recent developments and future perspectives

Recent advances in IBD therapy include stem cell-, antibody-, and small molecule-based treatments, targeting various inflammatory molecules and advancing biomarker discovery.

Recent advances in inflammatory bowel disease therapy.

CD64-targeted immunotherapeutics show potential in resolving chronic inflammation driven by M1-type dysregulated macrophages, offering a promising treatment strategy for autoimmune disorders.

CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases

Novel therapies using drug delivery systems, combination therapy, and tissue-targeted strategies can enhance the therapeutic benefits of current agents for managing chronic inflammatory diseases and cancers.

Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges

Apigenin shows potential as a safer, less toxic, and cost-effective alternative therapy for chronic inflammatory conditions like cancer, diabetes, cardiovascular diseases, and neuroinflammation.

Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin

Recent advances in IBD treatment include small molecules, apheresis therapy, improved intestinal microecology, cell therapy, and exosome therapy, aiming for mucosal healing rather than symptom-free daily life.

Treatment of Inflammatory Bowel Disease: A Comprehensive Review

Novel therapeutics based on endogenous mediators and mechanisms could offer new avenues for managing inflammation-based diseases.

Inflammatory Resolution: new opportunities for drug discovery

Bioresponsive drug delivery systems offer potential for targeted treatment of inflammatory diseases by responding to inflammation-associated biochemical signals.

Bioresponsive drug delivery systems for the treatment of inflammatory diseases

Natural bioactive compounds show potential in treating chronic skin wounds by reducing inflammation and bacterial infections, with potential applications in nanotechnology and biomaterial platforms.

Chronic Inflammation in Non-Healing Skin Wounds and Promising Natural Bioactive Compounds Treatment

Chronic inflammation contributes to various diseases, and targeting this inflammation with natural products offers new treatment opportunities.

The Role of Chronic Inflammation in Various Diseases and Anti‐inflammatory Therapies Containing Natural Products

Local drug delivery systems can reduce side effects and medication frequency in chronic inflammatory diseases, but challenges remain and underutilized technology in some applications.

Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities.

Traditional medicine, based on natural products from medicinal plants, animals, and functional foods, shows potential in treating chronic inflammatory diseases with lower side effects compared to chemical drugs.

Editorial: Traditional medicine and chronic inflammatory diseases

New research reveals genetic and environmental factors contribute to chronic inflammation, offering potential targets for therapies to prevent disease progression.

Susceptibility to chronic inflammation: an update

Chronic inflammation contributes to cancer development and immunotherapy targeting the tumor microenvironment may improve cancer treatment outcomes.

Chronic inflammation, cancer development and immunotherapy

What are the latest treatments for chronic inflammatory diseases?

These studies suggest that the latest treatments for chronic inflammatory diseases include biologic drugs, novel drug delivery systems, and personalized medicine approaches targeting specific inflammatory pathways and molecules.